Literature DB >> 12849365

Subcortical ischaemic vascular dementia.

Gustavo C Román1, Timo Erkinjuntti, Anders Wallin, Leonardo Pantoni, Helena C Chui.   

Abstract

Vascular dementia is the second most common type of dementia. The subcortical ischaemic form (SIVD) frequently causes cognitive impairment and dementia in elderly people. SIVD results from small-vessel disease, which produces either arteriolar occlusion and lacunes or widespread incomplete infarction of white matter due to critical stenosis of medullary arterioles and hypoperfusion (Binswanger's disease). Symptoms include motor and cognitive dysexecutive slowing, forgetfulness, dysarthria, mood changes, urinary symptoms, and short-stepped gait. These manifestations probably result from ischaemic interruption of parallel circuits from the prefrontal cortex to the basal ganglia and corresponding thalamocortical connections. Brain imaging (computed tomography and magnetic resonance imaging) is essential for correct diagnosis. The main risk factors are advanced age, hypertension, diabetes, smoking, hyperhomocysteinaemia, hyperfibrinogenaemia, and other conditions that can cause brain hypoperfusion such as obstructive sleep apnoea, congestive heart failure, cardiac arrhythmias, and orthostatic hypotension. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL)and some forms of cerebral amyloid angiopathy have a genetic basis. Treatment is symptomatic and prevention requires control of treatable risk factors.

Entities:  

Mesh:

Year:  2002        PMID: 12849365     DOI: 10.1016/s1474-4422(02)00190-4

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


  256 in total

1.  Vascular cognitive impairment.

Authors:  Laura Pedelty; David L Nyenhuis
Journal:  Curr Treat Options Cardiovasc Med       Date:  2006-05

Review 2.  [Arterial hypertension and dementia].

Authors:  R Scheid; H Voigt
Journal:  Nervenarzt       Date:  2005-02       Impact factor: 1.214

3.  Neurologic signs in relation to cognitive function in subcortical ischemic vascular dementia: a CREDOS (Clinical Research Center for Dementia of South Korea) study.

Authors:  Seong Hye Choi; Sangyun Kim; Seol-Heui Han; Duk L Na; Doh-Kwan Kim; Hae-Kwan Cheong; Jae-Hong Lee; Seong Yoon Kim; Chang Hyung Hong; So Young Moon; Jay C Kwon; Jung Eun Kim; Jee H Jeong; Hae Ri Na; Kyung Ryeol Cha; Sang Won Seo; Yong S Shim; Jun-Young Lee; Kyung Won Park
Journal:  Neurol Sci       Date:  2011-11-09       Impact factor: 3.307

4.  Treatment-induced leukoencephalopathy in primary CNS lymphoma presenting as lower body parkinsonism.

Authors:  Antonio Milia; Giuseppina Pilia; Maria Giuseppina Mascia; Francesco Maria Manconi
Journal:  J Neurooncol       Date:  2010-03-30       Impact factor: 4.130

5.  Association of depressed mood and mortality in older adults with and without cognitive impairment in a prospective naturalistic study.

Authors:  Helen Lavretsky; Ling Zheng; Michael W Weiner; Dan Mungas; Bruce Reed; Joel H Kramer; William Jagust; Helena Chui; Wendy J Mack
Journal:  Am J Psychiatry       Date:  2010-02-16       Impact factor: 18.112

Review 6.  Are the available apathy measures reliable and valid? A review of the psychometric evidence.

Authors:  Diana E Clarke; Jean Y Ko; Emily A Kuhl; Robert van Reekum; Rocio Salvador; Robert S Marin
Journal:  J Psychosom Res       Date:  2010-03-31       Impact factor: 3.006

7.  Age and diagnostic performance of Alzheimer disease CSF biomarkers.

Authors:  N Mattsson; E Rosén; O Hansson; N Andreasen; L Parnetti; M Jonsson; S-K Herukka; W M van der Flier; M A Blankenstein; M Ewers; K Rich; E Kaiser; M M Verbeek; M Olde Rikkert; M Tsolaki; E Mulugeta; D Aarsland; P J Visser; J Schröder; J Marcusson; M de Leon; H Hampel; P Scheltens; A Wallin; M Eriksdotter-Jönhagen; L Minthon; B Winblad; K Blennow; H Zetterberg
Journal:  Neurology       Date:  2012-02-01       Impact factor: 9.910

8.  Neuromarkers of the common angiotensinogen polymorphism in healthy older adults: A comprehensive assessment of white matter integrity and cognition.

Authors:  Lauren E Salminen; Peter R Schofield; Kerrie D Pierce; Yi Zhao; Xi Luo; Youdan Wang; David H Laidlaw; Ryan P Cabeen; Thomas E Conturo; David F Tate; Erbil Akbudak; Elizabeth M Lane; Jodi M Heaps; Jacob D Bolzenius; Laurie M Baker; Lee M Cagle; Robert H Paul
Journal:  Behav Brain Res       Date:  2015-08-28       Impact factor: 3.332

9.  Extracorporeal shock wave therapy effectively protects brain against chronic cerebral hypo-perfusion-induced neuropathological changes.

Authors:  Han-Tan Chai; Kuan-Hung Chen; Christopher Glenn Wallace; Chih-Hung Chen; Pei-Hsun Sung; Yung-Lung Chen; Chun-Man Yuen; Pei-Lin Shao; Cheuk-Kwan Sun; Hsueh-Wen Chang; Ching-Jen Wang; Mel S Lee; Hon-Kan Yip; Sheung-Fat Ko
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

10.  Albuminuria, cognitive functioning, and white matter hyperintensities in homebound elders.

Authors:  Daniel E Weiner; Keith Bartolomei; Tammy Scott; Lori Lyn Price; John L Griffith; Irwin Rosenberg; Andrew S Levey; Marshal F Folstein; Mark J Sarnak
Journal:  Am J Kidney Dis       Date:  2008-12-12       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.